Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response

Journal of Experimental Medicine

Volumn 185, Issue 9, 1997, Pages 1605-1617

  Steven, N M ^a   Annels, N E ^a   Kumar, A ^a   Leese, A M ^a   Kurilla, M G ^b   Rickinson, A B ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; INFECTIOUS MONONUCLEOSIS; LYMPHOBLASTOID CELL; PATHOGENESIS; PRIORITY JOURNAL; TARGET CELL; VIRUS GENOME; VIRUS INFECTION; VIRUS INTERFERENCE;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; CYTOTOXICITY, IMMUNOLOGIC; DNA-BINDING PROTEINS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HLA ANTIGENS; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; INFECTIOUS MONONUCLEOSIS; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES, CYTOTOXIC; TRANS-ACTIVATORS; VIRAL PROTEINS;

EID: 0030912070     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.9.1605     Document Type: Article

References (55)

1. Rickinson, A.B., and E. Kieff. 1996. Epstein-Barr virus. In Fields Virology. B.N. Fields, D.M. Knipe, and P.M. Howley, editors. Lippincott-Raven Publishers, Philadelphia. 2397-2446.
2. Sixbey, J.W., J.G. Nedrud, N. Raab-Traub, R.A. Hanes, and J.S. Pagano. 1984. Epstein-Barr virus replication in oropharyngeal epithelial cells. N. Engl. J. Med. 310:1225-1230.
3. Anagnostopoulos, I., M. Hummel, C. Kreschel, and H. Stein. 1995. Morphology, immunophenotype and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood. 85: 744-750.
4. Tierney, R.J., N. Steven, L.S. Young, and A.B. Rickinson. 1994. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68:7374-7385.
5. Yao, Q.Y., P. Ogan, M. Rowe, M. Wood, and A.B. Rickinson. 1989. Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers. Int. J. Cancer. 43:67-71.
6. Miyashita, E.M., B. Yang, K.M.C. Lam, D.H. Crawford, and D.A. Thorley-Lawson. 1995. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell. 80:593-601.
7. Steven, N.M., A.M. Leese, N.E. Annels, S.P. Lee, and A.B. Rickinson. 1996. Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory. J. Exp. Med. 184:1801-1813.
8. Murray, R.J., M.G. Kurilla, J.M. Brooks, W.A. Thomas, M. Rowe, E. Kieff, and A.B. Rickinson. 1992. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J. Exp. Med. 176:157-168.
9. Khanna, R., S.R. Burrows, M.G. Kurilla, C.A. Jacob, I.S. Misko, T.B. Sculley, E. Kieff, and D.J. Moss. 1992. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J. Exp. Med. 176:169-178.
10. Greenspan, J.S., D. Greenspan, E.T. Lennette, D.I. Abrams, M.A. Conant, V. Petersen, and U.K. Freese. 1985. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N. Engl. J. Med. 313:1564-1571.
11. Andiman, W.A., R. Eastman, K. Martin, B.Z. Katz, A. Rubinstein, J. Pitt, S. Pahura, and G. Miller. 1985. Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet. ii:1390-1393.
12. Thomas, J.A., F. Cotter, A.M. Hanby, L.Q. Long, P.R. Morgan, B. Bramble, and B. Bailey. 1993. Epstein-Barr virus-related oral T cell lymphoma associated with human immunodeficiency virus immunosuppression. Blood. 81:3350-3356.
13. Egan, J.J., J.P. Stewart, P.S. Hasleton, J.R. Arrand, K.B. Carroll, and A.A. Woodcock. 1995. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax. 50:1234-1239.
14. Borysiewicz, L.K., J.K. Hickling, S. Graham, J. Sinclair, M.P. Cranage, G.L. Smith, and J.G.P. Sissons. 1988. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J. Exp. Med. 168:919-931.
15. Riddell, S.R., M. Rabin, A.P. Geballe, W.J. Britt, and P.D. Greenberg. 1991. Class-I MHC-restricted cytotoxic lymphocyte-T recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. J. Immunol. 146:2795-2804.
16. Tigges, M.A., D. Koelle, K. Hartog, R.E. Sekulovich, L. Corey, and R.L. Burke. 1992. Human CD8+ herpes simplex virus-specific cytotoxic T lymphocyte clones recognise diverse virion protein antigens. J. Virol. 66:1622-1634.
17. Gilbert, M.J., S.R. Riddell, C.-R. Li, and P.D. Greenberg. 1993. Selective interference with class I major histocompatability complex presentation of the major immediate-early protein following infection with human cytomegalovirus. J. Virol. 67:3461-3469.
18. York, I.A., C. Roop, D.W. Andrews, S. Riddell, F. Graham, and D.C. Johnson. 1994. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell. 77:525-535.
19. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature (Lond.). 375: 411-415.
20. Fruh, K., K. Ahn, H. Djaballah, P. Sempe, P.M. van Endert, R. Tampe, P.A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature (Lond.). 375:415-418.
21. Jones, T.R., L.K. Hanson, L. Sun, J.S. Slater, R.M. Stenberg, and A.E. Campbell. 1995. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatability complex class I heavy chains. J. Virol. 69:4830-4841.
22. Wiertz, E.J.H.J., T.R. Jones, L. Sun, M. Bogyo, H.J. Geuze, and H.L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell. 84:769-779.
23. Kieff, E. 1996. Epstein-Barr virus and its replication. In Fields Virology. B.N. Fields, D.M. Knipe, and P.M. Howley, editors. Lippincott-Raven Publishers, Philadelphia. 2343-2396.
24. Rickinson, A.B., and D.J. Moss. 1997. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. In press.
25. Biggin, M., M. Bodescot, M. Perricaudet, and P.J. Farrell. 1987. Epstein-Barr virus gene expression in P3HR1-super-infected Raji cells. J. Virol. 61:3120-3132.
26. Takada, K., and Y. Ono. 1989. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63:445-449.
27. Cox, M.A., J. Leahy, and J.M. Hardwick. 1990. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators. J. Virol. 64: 313-321.
28. Kenney, S., E. Holley-Guthrie, E.-C. Mar, and M. Smith. 1989. The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators. J. Virol. 63:3878-3883.
29. Holley-Guthrie, E.A., E.B. Quinlivan, E.-C. Mar, and S. Kenney. 1990. The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner. J. Virol. 64:3753-3759.
30. Bogedain, C., H. Wolf, S. Modrow, G. Stuber, and W. Jilg. 1995. Specific cytotoxic T-lymphocytes recognize the immediate-early transactivator ZTA of Epstein-Barr virus. J. Virol. 69:4872-4879.
31. Young, L.S., R. Lau, M. Rowe, G. Niedobitek, G. Packham, F. Shanahan, D.T. Rowe, D. Greenspan, J.S. Greenspan, A.B. Rickinson, and P.J. Farrell. 1991. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J. Virol. 65:2868-2874.
32. Vroman, B., J. Luka, M. Rodriguez, and G.R. Pearson. 1985. Characterization of a major protein with a molecular weight of 160,000 associated with the viral capsid of Epstein-Barr virus. J. Virol. 52:107-113.
33. Hill, A.B., S.P. Lee, J.S. Haurum, N. Murray, Q.Y. Yao, M. Rowe, N. Signoret, A.B. Rickinson, and A.J. McMichael. 1995. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV) nuclear antigens fail to lyse the EBV-transformed B lymphoblastoid lines against which they were raised. J. Exp. Med. 181:2221-2228.
34. Lear, A.L., M. Rowe, M.G. Kurilla, S. Lee, S. Henderson, E. Kieff, and A.B. Rickinson. 1992. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. J. Virol. 66:7461-7468.
35. Burrows, S.R., A. Suhrbier, R. Khanna, and D.J. Moss. 1992. Rapid visual assay of cytotoxic T-cell specificity utilizing synthetic peptide induced T-cell-T-cell killing. Immunology. 76:174-175.
36. Burrows, S.R., T.B. Sculley, I.S. Misko, C. Schmidt, and D.J. Moss. 1990. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBNA3. J. Exp. Med. 171:345-350.
37. Burrows, S.R., J. Gardner, R. Khanna, T. Steward, D.J. Moss, S. Rodda, and A. Suhrbier. 1994. Five new cytotoxic T-cell epitopes identified within Epstein-Barr virus nuclear antigen 3. J. Gen. Virol. 75:2489-2493.
38. Falk, K., O. Rotzschke, B. Grahovac, D. Schendel, S. Stavanovic, V. Gnau, G. Jung, J.L. Strominger, and H.-G. Rammensee. 1993. Allele-specific peptide ligand motifs of HLA-C molecules. Prof. Natl. Acad. Sci. USA. 90:12005-12009.
39. Hunt, D.F., R.A. Henderson, J. Shabanowitz, K. Sakaguchi, H. Michel, N. Sevilir, A.L. Cox, E. Appella, and V.H. Engelhard. 1992. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science (Wash. DC). 255:1261-1263.
40. Sutkowski, N., T. Palkama, C. Ciurli, R.-P. Sekaly, D.A. Thorley-Lawson, and B.T. Huber. 1996. An Epstein-Barr virus-associated superantigen. J. Exp. Med. 184:971-980.
41. + T cells in acute infectious mononucleosis. Nat. Med. 2:906-911.
42. Townsend, A., J. Bastin, K. Gould, G. Brownlee, A. Andrew, D.B. Boyle, Y. Chan, and G. Smith. 1988. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigens. J. Exp. Med. 168:1211-1224.
43. Blake, N.W., S. Kettle, K.M. Law, K. Gould, J. Bastin, R.M. Townsend, and G.L. Smith. 1995. Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes. J. Gen. Virol. 76:2393-2398.
44. Lieberman, P.M., P. O'Hare, G.S. Hayward, and S.D. Hayward. 1986. Promiscuous trans activation of gene expression by an Epstein-Barr virus-encoded early nuclear protein. J. Virol. 60:140-148.
45. Kiehl, A., and D.I. Dorsky. 1991. Co-operation of Epstein-Barr virus DNA polymerase and EA-D (BMRF1) in vitro and colocalization in nuclei of infected cells. Virology. 184:330-340.
46. Neubling, C.M., and N. Mueller-Lantzsch. 1989. Identification and characterisation of an Epstein-Barr virus early antigen that is encoded by the Not1 repeats. J. Virol. 63:4609-4615.
47. Pearson, G.R., J. Luka, L. Petti, J. Sample, M. Birkenbach, D. Braun, and E. Kieff. 1987. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology. 160:151-161.
48. White, C.A., S.M. Cross, M.G. Kurilla, B.M. Kerr, C. Schmidt, I.S. Misko, R. Khanna, and D.J. Moss. 1996. Recruitment during infectious mononucleosis of CD3+ CD4+ CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1. Virology. 219:489-492.
49. Scotet, E., J. David-Ameline, M.-A. Peyrat, A. Moreau-Aubry, D. Pinczon, A. Lim, J. Even, G. Semana, J.M. Berthelot, R. Breathnach, et al. 1996. T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J. Exp. Med. 184:1791-1800.
50. Schendel, D.J., C. Reinhardt, P.J. Nelson, B. Maget, L. Pullen, G.W. Bornkamm, and A. Steinle. 1992. Cytotoxic T lymphocytes show HLA-C-restricted recognition of EBV-bearing cells and allorecognition of HLA class I molecules presenting self peptides. J. Immunol. 149:2406-2414.
51. Zemmour, J., and P. Parham. 1992. Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C. J. Exp. Med. 176:937-950.
52. Yao, Q.Y., A.B. Rickinson, J.S.H. Gaston, and M.A. Epstein. 1985. In vitro analysis of the Epstein-Barr virus: host balance in long-term renal allograft recipients. Int. J. Cancer. 35:43-49.
53. Gilbert, M., S.R. Riddell, B. Plachter, and R.D. Greenberg. 1996. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature (Lond.). 383:720-722.
54. Whitley, R.J. 1996. Herpes simplex viruses. In Fields Virology. B.N. Fields, D.M. Knipe, and P.M. Howley, editors. Lippincott-Raven Publishers, Philadelphia. 2297-2342.
55. Yao, Q.Y., A.B. Rickinson, and M.A. Epstein. 1985. A reexamination of the Epstein-Barr virus earner state in healthy seropositive individuals. Int. J. Cancer. 35:35-42.